AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MetaVia Inc. Director's Dealing 2018

Feb 12, 2018

34919_dirs_2018-02-12_791ba05e-0344-4a51-8ebd-e997711a587b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gemphire Therapeutics Inc. (GEMP)
CIK: 0001638287
Period of Report: 2018-02-08

Reporting Person: Reno Seth (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-08	Common Stock	P	14286	$7	Acquired	18286	Direct

Footnotes

F1: The shares were purchased in a confidentially marketed public offering pursuant to an Underwriting Agreement. The offering closed on February 12, 2018.